Pfizer Lung Drug Stops Deadly Child Cancers in Study

A Pfizer Inc. drug that has transformed treatment for adult lung cancers caused by a gene defect is now saving children with deadly tumors.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.